Depletion or inhibition of NAMPT has been shown to increase ROS in models of NSCLC (40), leukemia (43, 97), prostate cancer (19), breast cancer (61), glioblastoma (102), CRC (112), and others (85). The gene discussed is NAMPT; the disease is glioblastoma.